Current role
Randall Moreadith
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Serina Therapeutics, Inc. (SER)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Serina Therapeutics, Inc. (SER) | M.D., Ph.D. Chief Development Officer | $425,000 | $563,200 |
| 2023 | Serina Therapeutics, Inc. (SER) | M.D., Ph.D. Chief Development Officer Legacy Serina’s President and CEO | $336,723 | $433,880 |
| 2022 | Serina Therapeutics, Inc. (SER) | M.D., Ph.D. Chief Development Officer Legacy Serina’s President and CEO | $323,772 | $362,898 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.